4.6 Letter

Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy

Journal

Publisher

WILEY
DOI: 10.1111/jdv.16097

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available